Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles
NCT ID: NCT01645345
Last Updated: 2020-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2012-07-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fractional Radiofrequency for Treatment of Acne Scars and Wrinkles
NCT05827510
Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles
NCT04057768
Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar
NCT02207738
Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring
NCT04827680
Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars
NCT02103127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical improvement will be assessed by the investigator physician from the visual appearance of the treated area according to the following scale: -1 for exacerbation, 0 no change, 1 for 1%-25% improvement, 2 for 25%-50% improvement, 3 for 50%-75% improvement, and 4 for 75%-99% improvement. Adverse side effects will be scored by clinical evaluation of erythema, edema, and burns. Real-time assessments will be made as well by the investigators. Treatment and results will be documented in a Case Report Form and follow-up sessions (1, 5 days after the treatment and 1 month and 3 months after the treatment).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RF Pixel handpiece treatment
There is only one arm, and that is a treatment arm. For patients with wrinkles and acne scars, they are being treated with the RF Pixel handpiece to decrease the appearance of these cosmetic deficiencies. The improvement is documented in before and after photographs.
Alma Lasers Accent RF Pixel handpiece
Treatment with fractionated RF Pixel device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alma Lasers Accent RF Pixel handpiece
Treatment with fractionated RF Pixel device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically documented rolling and boxcar acne scars and/or wrinkles score of 2 or 3 per the Rao-Goldman scale (see section 6.5.1 for wrinkle classification).
* Limitation to acne scared and wrinkles area: face.
* Patients must commit to all follow-up visits.
Exclusion Criteria
* Bacterial or viral infection
* Impaired immune system
* Isotretinoin (Accutane, Amnesteem, Claravis, and Sotret) in the past 6 months
* Scleroderma
* Extensive radiation therapy
* Burns in the treatment area
* Poor healing in the treatment area
* Metal implants near the treatment area
* Implantable pacemaker or automatic defibrillator/cardioverter (AICD)
* Ablative/non-ablative cosmetic intervention (deep peeling) in the past 3 months in the areas to be treated
* Active cancer
* Active collagen or vascular disease
* Pregnancy or IVF procedure
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alma Lasers Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Metropolitan MD
Glenview, Illinois, United States
Dr. Zimmerman
Las Vegas, Nevada, United States
Victoria Cirillo-Hyland
Bryn Mawr, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
022012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.